Suppr超能文献

抑制鞘氨醇激酶-2 可抑制大鼠肝移植后的炎症反应并减轻移植物损伤。

Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.

机构信息

Department of Pharmaceutical & Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, United States of America.

出版信息

PLoS One. 2012;7(7):e41834. doi: 10.1371/journal.pone.0041834. Epub 2012 Jul 25.

Abstract

Inflammation mediates/promotes graft injury after liver transplantation (LT). This study investigated the roles of sphingosine kinase-2 (SK2) in inflammation after LT. Liver grafts were stored in UW solution with and without ABC294640 (100 µM), a selective inhibitor of SK2, before implantation. Hepatic sphingosine-1-phosphate (S1P) levels increased ∼4-fold after LT, which was blunted by 40% by ABC294640. Hepatic toll-like receptor-4 (TLR4) expression and nuclear factor-κB (NF-κB) p65 subunit phosphorylation elevated substantially after transplantation. The pro-inflammatory cytokines/chemokines tumor necrosis factor-α, interleukin-1β and C-X-C motif chemokine 10 mRNAs increased 5.9-fold, 6.1-fold and 16-fold, respectively following transplantation, while intrahepatic adhesion molecule-1 increased 5.7-fold and monocytes/macrophage and neutrophil infiltration and expansion of residential macrophage population increased 7.8-13.4 fold, indicating enhanced inflammation. CD4+ T cell infiltration and interferon-γ production also increased. ABC294640 blunted TLR4 expression by 60%, NF-κB activation by 84%, proinflammatory cytokine/chemokine production by 45-72%, adhesion molecule expression by 54% and infiltration of monocytes/macrophages and neutrophils by 62-67%. ABC294640 also largely blocked CD4+ T cell infiltration and interferon-γ production. Focal necrosis and apoptosis occurred after transplantation with serum alanine aminotransferase (ALT) reaching ∼6000 U/L and serum total bilirubin elevating to ∼1.5 mg/dL. Inhibition of SK2 by ABC294640 blunted necrosis by 57%, apoptosis by 74%, ALT release by ∼68%, and hyperbilirubinemia by 74%. Most importantly, ABC294640 also increased survival from ∼25% to ∼85%. In conclusion, SK2 plays an important role in hepatic inflammation responses and graft injury after cold storage/transplantation and represents a new therapeutic target for liver graft failure.

摘要

炎症介导/促进肝移植(LT)后的移植物损伤。本研究探讨了鞘氨醇激酶-2(SK2)在 LT 后炎症中的作用。在植入前,将肝移植物储存在 UW 溶液中,并添加和不添加 ABC294640(100 μM),一种 SK2 的选择性抑制剂。LT 后肝组织中鞘氨醇-1-磷酸(S1P)水平增加了约 4 倍,而 ABC294640 则使其降低了 40%。移植后,肝 Toll 样受体 4(TLR4)表达和核因子-κB(NF-κB)p65 亚单位磷酸化显著升高。移植后,促炎细胞因子/趋化因子肿瘤坏死因子-α、白细胞介素-1β和 C-X-C 基序趋化因子 10 mRNA 分别增加了 5.9 倍、6.1 倍和 16 倍,而肝内黏附分子-1 增加了 5.7 倍,单核细胞/巨噬细胞和中性粒细胞浸润以及驻留巨噬细胞群体的扩张增加了 7.8-13.4 倍,表明炎症增强。CD4+T 细胞浸润和干扰素-γ产生也增加。ABC294640 使 TLR4 表达降低 60%,NF-κB 激活降低 84%,促炎细胞因子/趋化因子产生降低 45-72%,黏附分子表达降低 54%,单核细胞/巨噬细胞和中性粒细胞浸润降低 62-67%。ABC294640 还在很大程度上阻断了 CD4+T 细胞的浸润和干扰素-γ的产生。移植后发生局灶性坏死和凋亡,血清丙氨酸氨基转移酶(ALT)达到约 6000 U/L,血清总胆红素升高至约 1.5 mg/dL。ABC294640 通过抑制 SK2 使坏死减少 57%,凋亡减少 74%,ALT 释放减少约 68%,高胆红素血症减少 74%。最重要的是,ABC294640 还将存活率从约 25%提高到约 85%。总之,SK2 在肝冷储存/移植后炎症反应和移植物损伤中发挥重要作用,是肝移植物衰竭的新治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验